Low-dose ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes: a review of 20 years' experience
Cheson, B.D.; Simon, R.
Seminars in Oncology 14(2 Suppl 1: 126-133
1987
ISSN/ISBN: 0093-7754 PMID: 3589688 Document Number: 293200
Document emailed within 1 workday
Related Documents
Yoshida, M.; Tsunoda, S.; Akutsu, M.; Furukawa, Y.; Takeda, K.; Akashi, M.; Komatsu, N.; Muroi, K.; Ikeda, K.; Ohsaka, A. 1987: The clinical effect of low-dose Ara-C in patients with refractory acute nonlymphocytic leukemia and myelodysplastic syndrome Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(4): 1057-1062Gerhartz, H.H.; Visani, G.; Delmer, A.; Zwierzina, H.; Ribeiro, M.; Jacobs, A.; Marcus, R.; Baumelou, M.; Fière, D.; Labar, B. 1989: Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group Bone Marrow Transplantation 4(Suppl 3): 36-37
Farhi, D.C. 1995: Myelodysplastic syndromes and acute myeloid leukemia. Diagnostic criteria and pitfalls Pathology Annual 30: 29-57
Steensma, D.P. 2007: The spectrum of molecular aberrations in myelodysplastic syndromes: in the shadow of acute myeloid leukemia Haematologica 92(6): 723-727
Xu, K.; Wang, L.; Hao, Y.; Shao, Z.; Meng, Q.; Li, K.; Chao, H.; Tang, K.; Wang, L. 1999: Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia Chinese Medical Journal 112(12): 1112-1118
Cortes, J.E.; Kantarjian, H.; O'Brien, S.; Keating, M.; Pierce, S.; Freireich, E.J.; Estey, E. 1995: Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes Leukemia 9(1): 115-117
Nasu, H.; Hibi, N.; Ohyashiki, J.H.; Hara, A.; Kubono, K.; Tsukada, Y.; Ando, K.; Iwama, H.; Hayashi, S.; Yahata, N.; Toyama, K.; Ohyashiki, K. 1998: Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes International Journal of Oncology 13(3): 525-530
Lai, J.L.; Preudhomme, C.; Zandecki, M.; Flactif, M.; Vanrumbeke, M.; Lepelley, P.; Wattel, E.; Fenaux, P. 1995: Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations Leukemia 9(3): 370-381
Kimura, K. 1987: A phase Ii study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(8): 2475-2481
Hines, J.D.; Mazza, J.J.; Oken, M.M.; Bennett, J.M.; Adelstein, D.J.; Keller, A.; O'Connell, M.J. 1985: High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase i Pilot Study for the Eastern Cooperative Oncology Group Seminars in Oncology 12(2 Suppl 3: 117-119
Bernell, P.; Kimby, E.; Hast, R. 1994: Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in acute myeloid leukemia evolving from myelodysplastic syndromes: a pilot study Leukemia 8(10): 1631-1639
Shaikh, B.S.; Frantz, E.; Lookingbill, D.P. 1987: Histologically proven leukemia cutis carries a poor prognosis in acute nonlymphocytic leukemia Cutis 39(1): 57-60
Schiffer, C.A.; Davis, R.B.; Mayer, R.J.; Peterson, B.A.; Lee, E.J. 1987: Combination chemotherapy with diaziquone and amsacrine in relapsed and refractory acute nonlymphocytic leukemia: a Cancer and Leukemia Group B Study Cancer Treatment Reports 71(9): 879-880
Rose, C.; Wattel, E.; Bastion, Y.; Berger, E.; Bauters, F.; Coiffier, B.; Fenaux, P. 1994: Treatment with very low-dose GM-CSF in myelodysplastic syndromes with neutropenia. A report on 28 cases Leukemia 8(9): 1458-1462
Preĭsler, K.D.; Raza, A. 1991: Treatment of acute nonlymphocytic leukemia Gematologiia i Transfuziologiia 36(1): 3-8
Neuwirtová, R.; Steruská, M.; Lukásová, M.; Háber, J.; Cieslar, P.; Kvasnicka, J. 1987: Personal experience in the treatment of the myelodysplastic syndromes Vnitrni Lekarstvi 33(5): 453-462
Zaccaria, A.; Testoni, N.; Rosti, G.; Bandini, G.; Cavazzini, G.; Covili Faggioli, G.; Tura, S. 1984: Case report of 11q- in M2-acute nonlymphocytic leukemia Nouvelle Revue Francaise d'Hematologie 26(5): 335-337
Raza, A.; Gill, L.M.; Rakowski, I.; Preisler, H.D. 1985: Spontaneous remission in acute nonlymphocytic leukemia New York State Journal of Medicine 85(6): 269-270
Berger, R.; Bernheim, A. 1989: Cytogenetics of acute nonlymphocytic leukemia in relapse Nouvelle Revue Francaise d'Hematologie 31(2): 153-154
Haus, O.; Kotlarek-Haus, S.; Potoczek, S.; Czarnecka, M.; Duszenko, E.; Makowska, I.; Mirowska, N.; Kuliczkowski, K. 2006: Myelodysplastic syndromes according to FAB and WHO classification. Single center experience Neoplasma 53(2): 136-143